| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.0000082924.75945.48 |
| P698 | PubMed publication ID | 12860902 |
| P50 | author | Pascal J Goldschmidt-Clermont | Q92278116 |
| Brian H Annex | Q105145959 | ||
| P2093 | author name string | Tao Wang | |
| Doris A Taylor | |||
| Chunming Dong | |||
| Anne M Pippen | |||
| David Gregg | |||
| Bryce H Davis | |||
| Frederick M Rauscher | |||
| Priya Ramaswami | |||
| P2860 | cites work | RETRACTED: Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells | Q56765519 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 457-463 | |
| P577 | publication date | 2003-07-14 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Aging, progenitor cell exhaustion, and atherosclerosis | |
| P478 | volume | 108 |
| Q36384416 | A Randomized, Controlled Pilot Study of the Effects of Acupuncture on Circulating Endothelial Progenitor Cells in Coronary Heart Disease |
| Q84742760 | A clinical cardiology perspective of thrombophilias |
| Q38124918 | Activated platelets correlate with mobilization of naïve CD34(+) cells and generation of CD34(+) /KDR(+) cells in the circulation. A meta-regression analysis |
| Q91386840 | Activation of heme oxygenase-1 by Ginkgo biloba extract differentially modulates endothelial and smooth muscle-like progenitor cells for vascular repair |
| Q37071934 | Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence |
| Q33745142 | Adriamycin nephropathy: a failure of endothelial progenitor cell-induced repair. |
| Q34295979 | Advanced Donor Age Impairs Bone Marrow Cell Therapeutic Efficacy for Cardiac Disease |
| Q39799183 | Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress |
| Q40642211 | Age and Human Regenerative Capacity Impact of Cardiovascular Risk Factors |
| Q89142435 | Age-Related Impaired Efficacy of Bone Marrow Cell Therapy for Myocardial Infarction Reflects a Decrease in B Lymphocytes |
| Q38596295 | Age-associated changes in regenerative capabilities of mesenchymal stem cell: impact on chronic wounds repair |
| Q37066948 | Age-associated vascular inflammation promotes monocytosis during atherogenesis. |
| Q26860478 | Age-related changes in brain support cells: Implications for stroke severity |
| Q52632093 | Age-related impairment of endothelial progenitor cell migration correlates with structural alterations of heparan sulfate proteoglycans. |
| Q38414962 | Age-related properties of the tumour vasculature in renal cell carcinoma |
| Q99365830 | Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6 |
| Q34012463 | Ageing, menopause, and ischaemic heart disease mortality in England, Wales, and the United States: modelling study of national mortality data |
| Q37439217 | Aging decreases expression and activity of glutathione peroxidase-1 in human endothelial progenitor cells |
| Q35063592 | Aging is associated with a proapoptotic endothelial progenitor cell phenotype. |
| Q34171737 | Aging is not associated with bone marrow-resident progenitor cell depletion |
| Q35947440 | Aging, atherosclerosis, and IGF-1 |
| Q33947816 | Aging-related atherosclerosis is exacerbated by arterial expression of tumor necrosis factor receptor-1: evidence from mouse models and human association studies |
| Q59296573 | Allogeneic adipose stem cell therapy in acute myocardial infarction |
| Q35658522 | Ambient Fine Particulate Matter Suppresses In Vivo Proliferation of Bone Marrow Stem Cells through Reactive Oxygen Species Formation |
| Q35022266 | Ambient fine particulate matter induces apoptosis of endothelial progenitor cells through reactive oxygen species formation |
| Q26764744 | Ambient particulate matter exposure and cardiovascular diseases: a focus on progenitor and stem cells |
| Q33831999 | An essential role for diet in exercise-mediated protection against dyslipidemia, inflammation and atherosclerosis in ApoE⁻/⁻ mice |
| Q46716639 | Angiogenesis, Cancer, and Vascular Aging. |
| Q37364728 | ApoA-I induced CD31 in bone marrow-derived vascular progenitor cells increases adhesion: implications for vascular repair. |
| Q34144489 | Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels |
| Q34144269 | Arterial aging: a journey into subclinical arterial disease |
| Q36007486 | Atherosclerosis and vascular aging as modifiers of tumor progression, angiogenesis, and responsiveness to therapy |
| Q37152177 | Atherosclerosis as a disease of failed endogenous repair |
| Q38000082 | Atherosclerosis, inflammation, genetics, and stem cells: 2012 update |
| Q41894963 | Autologous Bone Marrow Mononuclear Cell Transplantation Delays Progression of Carotid Atherosclerosis in Rabbits |
| Q34620003 | Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial |
| Q36428933 | Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering |
| Q36906139 | Bone marrow endothelial progenitors in atherosclerotic plaque resolution |
| Q27313372 | Bone marrow support of the heart in pressure overload is lost with aging |
| Q37776516 | Bone marrow-derived cells and hypertension |
| Q53889116 | Bone-marrow-derived cells for cardiac stem cell therapy: safe or still under scrutiny? |
| Q37005367 | Building solutions for cardiovascular disease in women |
| Q90019127 | CD34+ circulating cells display signs of immune activation in patients with acute coronary syndrome |
| Q36406439 | Cardiac cell-repair therapy: clinical issues |
| Q37060620 | Cardiovascular cell therapy and endogenous repair |
| Q35277772 | Cell membrane damage is involved in the impaired survival of bone marrow stem cells by oxidized low-density lipoprotein |
| Q36304220 | Cell therapy for cardiovascular disease: what cells, what diseases and for whom? |
| Q36770489 | Cell therapy for left ventricular remodeling |
| Q33295408 | Cell therapy in congestive heart failure |
| Q36559155 | Cell therapy: a 21st-century hope for treating cardiovascular disease--what do the next 5 years hold? |
| Q37739010 | Cell-based methods for ex vivo evaluation of human endothelial biology. |
| Q38044330 | Cell-specific insulin resistance: implications for atherosclerosis |
| Q37178001 | Cells for the treatment, prevention, and cure of cardiovascular disease. |
| Q37859918 | Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targets |
| Q26778013 | Changes in Regenerative Capacity through Lifespan |
| Q36011869 | Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial |
| Q37471442 | Characterization of umbilical cord blood-derived late outgrowth endothelial progenitor cells exposed to laminar shear stress. |
| Q35584749 | Childhood origins of endothelial dysfunction |
| Q33633032 | Chromatin-modifying agents convert fibroblasts to OCT4+ and VEGFR-2+ capillary tube-forming cells |
| Q33796542 | Circulating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk. |
| Q36469490 | Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease. |
| Q43461095 | Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients' Age and Disease Duration. |
| Q92212788 | Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes: Translational Insights Into the Prevention of Ischemic Complications in Diabetes |
| Q38856511 | Circulating Progenitor Cells Identify Peripheral Arterial Disease in Patients With Coronary Artery Disease |
| Q79086919 | Circulating Progenitor Cells Regenerate Endothelium of Vein Graft Atherosclerosis, Which Is Diminished in ApoE-Deficient Mice |
| Q98895737 | Circulating Progenitor Cells in Patients With Coronary Artery Disease and Renal Insufficiency |
| Q41917796 | Circulating angiogenic cells and Alzheimer's disease: contribution of the bone marrow to the pathogenesis of the disease. |
| Q36490364 | Circulating endothelial and progenitor cells: Evidence from acute and long-term exercise effects |
| Q51949397 | Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age. |
| Q35954189 | Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure |
| Q35954256 | Circulating endothelial progenitor cells in patients with cardiac syndrome X. |
| Q47958476 | Circulating endothelial progenitor cells in postmenopausal women with and without coronary artery disease. |
| Q36517055 | Clinical and therapeutical implications of EPC biology in atherosclerosis |
| Q40250933 | Clinical trials in stem cell therapy: pitfalls and lessons for the future |
| Q89481046 | Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis |
| Q38114011 | Concise review: endothelial stem and progenitor cells and their habitats |
| Q84970911 | Coronary vasoconstrictor responses are attenuated in young women as compared with age-matched men |
| Q36207052 | Correlation between the functional impairment of bone marrow-derived circulating progenitor cells and the extend of coronary artery disease. |
| Q35934133 | Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation |
| Q26772290 | Critical Roles of Reactive Oxygen Species in Age-Related Impairment in Ischemia-Induced Neovascularization by Regulating Stem and Progenitor Cell Function |
| Q33885504 | Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease |
| Q34044275 | Danshen protects endothelial progenitor cells from oxidized low-density lipoprotein induced impairment |
| Q37071512 | Decitabine enhances stem cell antigen-1 expression in cigarette smoke extract-induced emphysema in animal model |
| Q39453014 | Declined Expression of Histone Deacetylase 6 Contributes to Periodontal Ligament Stem Cell Aging |
| Q48855551 | Decreased circulating endothelial progenitor cell levels and function in essential hypertensive patients with electrocardiographic left ventricular hypertrophy |
| Q34168401 | Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease |
| Q30480280 | Delivery of stem cells to porcine arterial wall with echogenic liposomes conjugated to antibodies against CD34 and intercellular adhesion molecule-1. |
| Q35609188 | Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale |
| Q50554040 | Diabetes and aging: a different phenotypic commitment of circulating and resident stem cells? |
| Q30428895 | Diabetes-associated macrovascular complications: cell-based therapy a new tool? |
| Q51069248 | Diesel exhaust particles impair endothelial progenitor cells, compromise endothelial integrity, reduce neoangiogenesis, and increase atherogenesis in mice. |
| Q45236400 | Do atherosclerosis and chronic bladder ischemia really play a role in detrusor dysfunction of old age? |
| Q29304005 | Donor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1-Mediated Inflammatory Response |
| Q90149326 | Downregulation of MicroRNA-206 Alleviates the Sublethal Oxidative Stress-Induced Premature Senescence and Dysfunction in Mesenchymal Stem Cells via Targeting Alpl |
| Q30415670 | Early accelerated senescence of circulating endothelial progenitor cells in premature coronary artery disease patients in a developing country - a case control study. |
| Q35509900 | Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients |
| Q24594384 | Effect of cellular senescence on the albumin permeability of blood-derived endothelial cells |
| Q36656074 | Effects of Aging and Hypercholesterolemia on Oxidative Stress and DNA Damage in Bone Marrow Mononuclear Cells in Apolipoprotein E-deficient Mice |
| Q34167012 | Effects of G-CSF on serum cholesterol and development of atherosclerotic plaque in apolipoprotein E-deficient mice |
| Q43100960 | Effects of atorvastatin on the regeneration of pancreatic {beta}-cells after streptozotocin treatment in the neonatal rodent |
| Q36995124 | Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions |
| Q49787990 | Endothelial Cell Metabolism. |
| Q37812341 | Endothelial Damage and Regeneration: The Role of the Renin-Angiotensin-Aldosterone System |
| Q37237936 | Endothelial Progenitor Cell Levels Predict Future Physical Function: An Exploratory Analysis From the VA Enhanced Fitness Study |
| Q47141294 | Endothelial Progenitor Cells for Ischemic Stroke: Update on Basic Research and Application |
| Q28219326 | Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium |
| Q36961234 | Endothelial precursor cells |
| Q37645668 | Endothelial progenitor cell senescence--is there a role for estrogen? |
| Q36367251 | Endothelial progenitor cells and their potential clinical applications in peripheral arterial disease |
| Q37563882 | Endothelial progenitor cells and their potential clinical implication in cardiovascular disorders |
| Q34444790 | Endothelial progenitor cells as factors in neovascularization and endothelial repair |
| Q35765879 | Endothelial progenitor cells enter the aging arena |
| Q36011477 | Endothelial progenitor cells in atherosclerosis |
| Q35604291 | Endothelial progenitor cells in cardiovascular diseases: from biomarker to therapeutic agent |
| Q36438473 | Endothelial progenitor cells in chronic renal insufficiency |
| Q36799382 | Endothelial progenitor cells in health and atherosclerotic disease |
| Q33302128 | Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis--results from a large population-based study |
| Q36772905 | Endothelial progenitor cells: a promising therapeutic alternative for cardiovascular disease |
| Q40311493 | Endothelial progenitor cells: from bench to bedside |
| Q37362743 | Endothelial progenitor cells: markers of vascular reparative capacity |
| Q33705402 | Endothelial progenitor cells: therapeutic perspective for ischemic stroke |
| Q21198698 | Endothelial progenitor cells: what use for the cardiologist? |
| Q33995043 | Endothelial progenitors encapsulated in bioartificial niches are insulated from systemic cytotoxicity and are angiogenesis competent |
| Q35559471 | Endothelial progenitors in sepsis: vox clamantis in deserto? |
| Q36571048 | Epigenetic memory loss in aging oligodendrocytes in the corpus callosum |
| Q41105914 | Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis |
| Q34317991 | Evolving strategies for the treatment of microvascular angina in women |
| Q35030632 | Exercise induces stromal cell-derived factor-1α-mediated release of endothelial progenitor cells with increased vasculogenic function. |
| Q42691487 | Experimental study on apoptosis of TNFR1 receptor pro-endothelial progenitor cells activated by high glucose induced oxidative stress |
| Q33409683 | Extracellular calcium increases CXCR4 expression on bone marrow-derived cells and enhances pro-angiogenesis therapy |
| Q46921519 | Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction |
| Q35606632 | Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1). |
| Q40487906 | Genome-wide epigenetic and proteomic analysis reveals altered Notch signaling in EPC dysfunction |
| Q37738347 | Genomics of premature atherosclerotic vascular disease. |
| Q37538723 | Genous endothelial progenitor cell-capturing stent system: a novel stent technology |
| Q48886329 | Globular adiponectin improves high glucose-suppressed endothelial progenitor cell function through endothelial nitric oxide synthase dependent mechanisms |
| Q35078469 | GroEL1, a heat shock protein 60 of Chlamydia pneumoniae, impairs neovascularization by decreasing endothelial progenitor cell function |
| Q90047347 | Growth hormone-releasing hormone promotes therapeutic effects of peripheral blood endothelial progenitor cells in ischemic repair |
| Q42723029 | Hard luck stories: the reality of endothelial progenitor cells continues to fall short of the promise |
| Q38021672 | Heartache and heartbreak--the link between depression and cardiovascular disease |
| Q38656088 | High glucose-induced endothelial progenitor cell dysfunction |
| Q35889139 | High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells |
| Q40122462 | Human mesenchymal stem cells improve myocardial performance in a splenectomized rat model of chronic myocardial infarction |
| Q34226053 | Human umbilical cord blood endothelial progenitor cells decrease vein graft neointimal hyperplasia in SCID mice |
| Q33283815 | Hypercholesterolemia suppresses Kir channels in porcine bone marrow progenitor cells in vivo |
| Q21562488 | INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis |
| Q49171170 | Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials |
| Q53643061 | Imbalance between detached circulating endothelial cells and endothelial progenitor cells in chronic kidney disease. |
| Q37202978 | Immune system in renal injury and repair: burning the candle from both ends? |
| Q50079370 | Impact of malondialdehyde-modified low-density lipoprotein on coronary plaque vulnerability in patients not receiving lipid-lowering therapy: a whole coronary analysis with multislice-computed tomography |
| Q35501916 | Impaired CXCR4 expression and cell engraftment of bone marrow-derived cells from aged atherogenic mice |
| Q34718887 | Insulin resistance impairs circulating angiogenic progenitor cell function and delays endothelial regeneration |
| Q34349858 | Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging |
| Q35575179 | Involvement of Progenitor Cells in Vascular Repair |
| Q37131315 | Ischemia-induced Angiogenesis is Attenuated in Aged Rats |
| Q42431495 | Jay and Jeanie Schottenstein prize in cardiovascular science: predicting cardiovascular illnesses for the 21(st) century, and the unpredictable.. |
| Q50193037 | L-carnitine significantly decreased aging of rat adipose tissue-derived mesenchymal stem cells. |
| Q42874906 | Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty: in vivo and in vitro studies |
| Q35750878 | Long-term, regular remote ischemic preconditioning improves endothelial function in patients with coronary heart disease |
| Q35562127 | Loss of bone marrow-derived vascular progenitor cells leads to inflammation and atherosclerosis |
| Q35677070 | Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells |
| Q51638425 | Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing, and telomere shortening. |
| Q47140121 | MeCP2 mediated dysfunction in senescent EPCs |
| Q57822218 | Mechanisms of Vascular Aging |
| Q63866082 | Mesenchymal Stromal Cell Characteristics and Regenerative Potential in Cardiovascular Disease: Implications for Cellular Therapy |
| Q37034383 | MicroRNA-10A* and MicroRNA-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group A2 |
| Q36362162 | Microvascular Function and Endothelial Progenitor Cells in Patients with Severe Hypercholesterolemia and the Familial Hypercholesterolemia Phenotype |
| Q85157593 | Mitochondrial damage-induced impairment of angiogenesis in the aging rat kidney |
| Q38125279 | Molecular biology of atherosclerosis |
| Q34120522 | Molecular evidence for arterial repair in atherosclerosis |
| Q37254899 | Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes |
| Q35231300 | Mononuclear cell therapy attenuates atherosclerosis in apoE KO mice |
| Q36335137 | Mononuclear cell therapy reverts cuff-induced thrombosis in apolipoprotein E-deficient mice |
| Q36304191 | Myocardial-cell replacement: the science, the clinic and the future |
| Q38183938 | Next-generation DES: the COMBO dual therapy stent with Genous endothelial progenitor capturing technology and an abluminal sirolimus matrix |
| Q21245469 | Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis |
| Q33455791 | Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation |
| Q35582269 | On the Memory of a Chronic Illness |
| Q36900747 | Organ-derived coatings on electrospun nanofibers as ex vivo microenvironments |
| Q36877532 | Overexpression of Nitric Oxide Synthase Restores Circulating Angiogenic Cell Function in Patients With Coronary Artery Disease: Implications for Autologous Cell Therapy for Myocardial Infarction |
| Q34915674 | Overexpression of the cell cycle inhibitor p16INK4a promotes a prothrombotic phenotype following vascular injury in mice |
| Q46979835 | Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase |
| Q38022767 | Oxidized low density lipoprotein, stem cells, and atherosclerosis |
| Q38569611 | PREMATURE VASCULAR SENESCENCE IN METABOLIC SYNDROME: COULD IT BE PREVENTED AND REVERSED BY A SELENORGANIC ANTIOXIDANT AND PEROXYNITRITE SCAVENGER EBSELEN? |
| Q24811751 | Paclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice. |
| Q35693660 | Perspectives of Targeting mTORC1-S6K1 in Cardiovascular Aging |
| Q45385963 | Plaque regression and progenitor cell mobilization with intensive lipid elimination regimen (PREMIER) trial design |
| Q37035357 | Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells. |
| Q37568677 | Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients |
| Q37016190 | Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure |
| Q36444277 | Premature senescence of endothelial cells: Methusaleh's dilemma |
| Q30432160 | Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies |
| Q87993873 | Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes |
| Q40457855 | Progenitor cell therapy of ischemic heart disease: the new frontier. |
| Q37053167 | Progenitor cells and vascular disease |
| Q36275672 | Progenitor cells in vascular disease. |
| Q38522829 | Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation |
| Q37299299 | Progression of motor neuron disease is accelerated and the ability to recover is compromised with advanced age in rNLS8 mice |
| Q34980958 | Protein engineering to develop a redox insensitive endothelial nitric oxide synthase |
| Q91760354 | Proteomic analysis of the secretome of adipose tissue-derived murine mesenchymal cells overexpressing telomerase and myocardin |
| Q90128076 | Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study |
| Q91896447 | Reactive Oxygen Species and Nrf2: Functional and Transcriptional Regulators of Hematopoiesis |
| Q36203750 | Reactive oxygen species contribute to dysfunction of bone marrow hematopoietic stem cells in aged C57BL/6 J mice. |
| Q34271579 | Reactive oxygen species mediate oxidized low-density lipoprotein-induced inhibition of oct-4 expression and endothelial differentiation of bone marrow stem cells |
| Q44600218 | Reduced circulating endothelial progenitor cells in thromboangiitis obliterans (Buerger's disease). |
| Q45976155 | Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis. |
| Q35607738 | Relation between the frequency of CD34⁺ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes |
| Q44669077 | Renal function and outcomes in acute coronary syndrome: impact of clopidogrel |
| Q36410447 | Renovation of the injured heart with myocardial tissue engineering |
| Q37322166 | Review article: endothelial progenitor cells in renal disease |
| Q47164880 | Sex Differences in Circulating Progenitor Cells |
| Q51708903 | Sex-based differences in vascular repair with bone marrow cell therapy: relevance of regulatory and Th2-type cytokines. |
| Q38520485 | Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease |
| Q38601272 | Stem cell therapy for cardiac regeneration: hits and misses. |
| Q38262671 | Stem cell therapy to treat heart ischaemia: implications for diabetes cardiovascular complications |
| Q37261623 | Stem cells for heart cell therapies |
| Q36446920 | Stem cells for the ischaemic heart |
| Q35798011 | Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists |
| Q35127582 | Superior therapeutic potential of young bone marrow mesenchymal stem cells by direct intramyocardial delivery in aged recipients with acute myocardial infarction: in vitro and in vivo investigation. |
| Q49215161 | The Aging Risk and Atherosclerosis: A Fresh Look at Arterial Homeostasis |
| Q43375962 | The Effect of Granulocyte Colony-Stimulating Factor on the Progression of Atherosclerosis in Animal Models: A Meta-Analysis. |
| Q24605207 | The Effect of Stress-Induced Senescence on Aging Human Cord Blood-Derived Endothelial Cells |
| Q50096388 | The Non-cardiomyocyte Cells of the Heart. Their Possible Roles in Exercise-Induced Cardiac Regeneration and Remodeling. |
| Q37560012 | The Role of Immunogenicity in Cardiovascular Disease |
| Q47643546 | The adverse effects of environmental noise exposure on oxidative stress and cardiovascular risk. |
| Q39951752 | The basics of cell therapy to treat cardiovascular disease: one cell does not fit all. |
| Q36892494 | The impact of insulin resistance on endothelial function, progenitor cells and repair |
| Q36982520 | The number and function of circulating CD34(+)CD133(+) progenitor cells decreased in stable coronary artery disease but not in acute myocardial infarction |
| Q37276042 | The promise of cell-based therapies for diabetic complications: challenges and solutions |
| Q35148886 | The relationship between endothelial progenitor cell populations and epicardial and microvascular coronary disease-a cellular, angiographic and physiologic study |
| Q42881647 | The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice |
| Q36275663 | The role of circulating precursors in vascular repair and lesion formation. |
| Q37734546 | The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development |
| Q36182725 | Thematic review series: The immune system and atherogenesis. Cytokine regulation of macrophage functions in atherogenesis |
| Q46470925 | Therapeutic strategies for endothelial dysfunction |
| Q57113823 | Thrombotic preparedness in aging: a translatable construct for thrombophilias? |
| Q37034391 | Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells |
| Q35676882 | Transplantation of cryopreserved human umbilical cord blood-derived endothelial progenitor cells induces recovery of carotid artery injury in nude rats |
| Q95856528 | Unveiling the Role of Inflammation and Oxidative Stress on Age-Related Cardiovascular Diseases |
| Q33747889 | Use of senescence-accelerated mouse model in bleomycin-induced lung injury suggests that bone marrow-derived cells can alter the outcome of lung injury in aged mice |
| Q50300607 | Vascular Calcification: Is it rather a Stem/Progenitor Cells Driven Phenomenon? |
| Q34818981 | Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes |
| Q37340859 | Vascular effects of a low-carbohydrate high-protein diet. |
| Q35868133 | Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? |
| Q40292922 | Vascular stem cells: a new concept in the pathogenesis of atherosclerosis and interventions for coronary heart disease |
| Q34103164 | Voluntary running suppresses proinflammatory cytokines and bone marrow endothelial progenitor cell levels in apolipoprotein-E-deficient mice |
| Q35556437 | Will periodic intravenous injections of conditioned bone marrow cells effectively reduce atherosclerosis? |
| Q88210842 | [Effect of inflammaging on periodontitis] |
| Q51640206 | c-kit-immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions. |
Search more.